A groundbreaking achievement has been reached in the fight against malaria. Novartis announced today that its revolutionary treatment has received formal approval to treat malaria in newborns and infants, signaling a major leap forward in global health. This cutting-edge pharmaceutical will now be available in countries where malaria is most preva